From kjrh.com
()
Juvenile Diabetes Research Foundation International
Juvenile Diabetes Research Foundation International is a nonprofit organization that conducts diabetes research. The organization is based in New York, NY and managed by Peter Van Etten. Its official home on the web is http://www.jdf.org
The Juvenile Diabetes Research Foundation held its annual Christmas Hope House benefit Sunday.
- Build-A-Bear Workshop to Raise Funds for Juvenile Diabetes Research Foundation (rss.prnewswire.com)
- Juvenile - Employees Making a Difference One Step at a Time (ad-hoc-news.de)
- Employees Making a Difference One Step at a Time (businesswire.com)
Staff raises almost $9,000 for Juvenile Diabetes Research Foundation
From sirsidynix.com
()
- 2,000 walk for Juvenile Diabetes cure (danvilleweekly.com)
Twilight star Kristen Stewart hit Dodgers Stadium in LA yesterday to kick off the Juvenile Diabetes Research Foundation’s Walk to Cure Diabetes. “It’s amazing to be around such inspiring people,” the 19-year-old actress said during her surprise guest appearance before cutting the ribbon with boxing legend Sugar Ray Leonard.
The JRDF hopes to raise more than [...]
More perspectives...
From ecorazzi.com
()
A benefit dinner for the Juvenile Diabetes Research Fund is set for 6:30 p.m. Wednesday and Thursday, Nov. 11 and 12, at Aubreys Yorkshire Pub & Eatery, 601 Sixth Ave. in St. Albans. Executive Chef Dennis O. Harris II is the father of an 8-year-ol...
From dailymail.com
()
- Walk to raise money for juvenile diabetes, honor child's memory (gadsdentimes.com)
BERKELEY, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced plans to initiate an investigator sponsored Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. The trial will be sponsored by the Juvenile Diabetes Research Foundation International (JDRF), the largest patient advocacy...
From globenewswire.com
()
- Phase 2 Trial of XOMA LLC 052 to be Initiated in Type 1 Diabetes Patients (rss.biospace.com)
